Share

December 2013; 3 (6) Clinical and Ethical Challenges

Primary dystonia misinterpreted as Parkinson disease

Video case presentation and practical clues

Olga Klepitskaya, Alexander J. Neuwelt, Tam Nguyen, Maureen Leehey
First published October 3, 2013, DOI: https://doi.org/10.1212/CPJ.0b013e3182a78eb5
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
634

Share

Article Information

vol. 3 no. 6 469-474
DOI: 
https://doi.org/10.1212/CPJ.0b013e3182a78eb5
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published October 3, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Olga Klepitskaya, MD,
    2. Alexander J. Neuwelt, MD,
    3. Tam Nguyen, MD and
    4. Maureen Leehey, MD
  1. Olga Klepitskaya, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. has received compensation for travel to the investigator meeting from USWorldMeds and Ipsen Biopharmaceuticals

    Editorial Boards:

    1. Brain Disorders and Therapy. Editorial board member

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Medtronic Neuromodulation, Merz Pharmaceutical, TEVA Pharmaceuticals

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical procedures or imaging studies:

    1. performs botulinum toxin injections (10% clinical effort) and involved in Deep Brain Stimulation treatment of movement disorders (45% clinical effort)

    Research Support, Commercial Entities:

    1. Neurologix, Schwartz Biosciences, Impax Pharmaceuticals, Solstice Neurosciences, Biotie Therapies, Ipsen Biopharmaceuticals

    Research Support, Government Entities:

    1. NIH-NINDS

    Research Support, Academic Entities:

    1. University of Colorado Denver, Department of Neurology, academic enrichment fund

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. has participated in a medical-legal cases.

  2. Alexander J. Neuwelt, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Tam Nguyen, MD and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Maureen Leehey, MD
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Gerson Lehman

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical procedures or imaging studies:

    1. performs botulinum toxin injections (5% of effort)

    Research Support, Commercial Entities:

    1. funded as a site investigator in a multi-center trials funded from Neurologix, Inc. (2008 - 2011), Schwartz Biosciences, Inc. (2008- 2012), and Impax pharmaceuticals (2011-2012)

    Research Support, Government Entities:

    1. NINDS, 2U1-NS044479, site investigator, 2002-2015; NIA, 2007-2012, RL1 AG032115, site investigator

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Law office of Michael Goodman, PC, deposition, 2012; Amex Assurance Company, expert witness, 2012

  1. Department of Neurology, University of Colorado, Denver.
  1. Correspondence to:
    Olga.Klepitskaya{at}ucdenver.edu
View Full Text

Article usage

Article usage: October 2013 to December 2021

AbstractFullPdfSource
Oct 2013237018Highwire
Nov 20139446Highwire
Dec 20135804142Highwire
Jan 20143591221Highwire
Feb 201416865Highwire
Mar 201419839Highwire
Apr 201412323Highwire
May 20148923Highwire
Jun 20147417Highwire
Jul 20144901Highwire
Aug 20146413Highwire
Sep 20144012Highwire
Oct 20144402Highwire
Nov 20145814Highwire
Dec 20144100Highwire
Jan 20152601Highwire
Jan 2015085pmc
Feb 20152500Highwire
Feb 20150293pmc
Mar 20153502Highwire
Mar 20150304pmc
Apr 20151802Highwire
Apr 20150150pmc
May 20152002Highwire
May 2015053pmc
Jun 20152100Highwire
Jun 2015094pmc
Jul 20153032Highwire
Jul 20150122pmc
Aug 20151610Highwire
Aug 2015050pmc
Sep 20152713Highwire
Sep 20150103pmc
Oct 20151100Highwire
Oct 20150160pmc
Nov 20152501Highwire
Nov 20150104pmc
Dec 20153110Highwire
Dec 20150175pmc
Jan 20162501Highwire
Jan 20160101pmc
Feb 20162006Highwire
Feb 20160172pmc
Mar 20162300Highwire
Mar 2016091pmc
Apr 20163102Highwire
Apr 20160147pmc
May 20164100Highwire
May 2016054pmc
Jun 20162901Highwire
Jun 2016075pmc
Jul 20161600Highwire
Jul 20160181pmc
Aug 20161202Highwire
Aug 20160231pmc
Sep 20161100Highwire
Sep 20160152pmc
Oct 20162501Highwire
Oct 20160190pmc
Nov 20163000Highwire
Nov 20160124pmc
Dec 20161700Highwire
Dec 20160140pmc
Jan 20171300Highwire
Jan 2017070pmc
Feb 20173401Highwire
Feb 20170157pmc
Mar 20171200Highwire
Mar 2017091pmc
Apr 20171800Highwire
Apr 201711412pmc
May 20171000Highwire
May 201752326pmc
Jun 2017800Highwire
Jun 201742225pmc
Jul 2017700Highwire
Jul 201721820pmc
Aug 20171000Highwire
Aug 201762123pmc
Sep 2017500Highwire
Sep 201721715pmc
Oct 2017601Highwire
Oct 201733033pmc
Nov 20171200Highwire
Nov 201732832pmc
Dec 20171824Highwire
Jan 20182020Highwire
Feb 20183921Highwire
Mar 20183311Highwire
Apr 20182201Highwire
Apr 201844248pmc
May 20182700Highwire
Jun 20182200Highwire
Jun 201835355pmc
Jul 20182000Highwire
Aug 20182001Highwire
Aug 201834150pmc
Sep 2018900Highwire
Oct 20181600Highwire
Nov 20181300Highwire
Dec 20181400Highwire
Jan 20191400Highwire
Feb 20191401Highwire
Mar 20192002Highwire
Apr 2019801Highwire
May 20193700Highwire
Jun 20192611Highwire
Jul 2019800Highwire
Aug 2019420Highwire
Sep 20192002Highwire
Oct 20192000Highwire
Nov 20191701Highwire
Dec 20191301Highwire
Jan 20201604Highwire
Feb 20201400Highwire
Mar 20202214Highwire
Apr 2020900Highwire
May 202036211Highwire
Jun 2020700Highwire
Jul 20201701Highwire
Aug 20201713Highwire
Sep 20201812Highwire
Oct 20202442Highwire
Nov 20201320Highwire
Dec 20201710Highwire
Jan 20212714Highwire
Feb 20211600Highwire
Mar 20211800Highwire
Apr 2021901Highwire
May 20211301Highwire
Jun 20211131Highwire
Jul 20212422Highwire
Aug 20212811Highwire
Sep 20212305Highwire
Oct 20213003Highwire
Nov 20211436Highwire
Dec 20214504Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me